UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 331

Sortiert nach

BRAF V600E Inhibition in Anaplastic Thyroid Cancer

The New England journal of medicine, 2013-02, Vol.368 (7), p.684-685

2013

Volltextzugriff (PDF)

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway

PloS one, 2011-12, Vol.6 (12), p.e28973

2011

Volltextzugriff (PDF)

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

Cancer discovery, 2014-01, Vol.4 (1), p.80-93

2014

Volltextzugriff (PDF)

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial

The lancet oncology, 2017-05, Vol.18 (5), p.654-662

2017

Volltextzugriff (PDF)

Do We Need a Different Set of Response Assessment Criteria for Tumor Immunotherapy?

Clinical cancer research, 2009-12, Vol.15 (23), p.7116-7118

2009

Volltextzugriff (PDF)

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Clinical cancer research, 2011-06, Vol.17 (12), p.4101-4109

2011

Volltextzugriff (PDF)

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Journal of clinical oncology, 2005-12, Vol.23 (35), p.8968-8977

2005

Volltextzugriff (PDF)

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1040-1050

2008

Volltextzugriff (PDF)

Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Induced Anemia

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2838-2847

2009

Volltextzugriff (PDF)

Differential Effects of Prostaglandin Derived from ω-6 and ω-3 Polyunsaturated Fatty Acids on COX-2 Expression and IL-6 Secretion

Proceedings of the National Academy of Sciences - PNAS, 2003-02, Vol.100 (4), p.1751-1756

2003

Volltextzugriff (PDF)

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

Clinical cancer research, 2009-10, Vol.15 (19), p.6267-6276

2009

Volltextzugriff (PDF)

Current Developments in Cancer Vaccines and Cellular Immunotherapy

Journal of clinical oncology, 2003-06, Vol.21 (12), p.2415-2432

2003

Volltextzugriff (PDF)

A careful reassessment of anthracycline use in curable breast cancer

NPJ breast cancer, 2021-10, Vol.7 (1), p.134-134, Article 134

2021

Volltextzugriff (PDF)

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

Clinical cancer research, 2006-05, Vol.12 (9), p.2817-2825

2006

Volltextzugriff (PDF)

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

Cancer, 2002-08, Vol.95 (4), p.888-895

2002

Volltextzugriff (PDF)

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade

Clinical cancer research, 2009-01, Vol.15 (1), p.390-399

2009

Volltextzugriff (PDF)

Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma

Neoplasia (New York, N.Y.), 2010-08, Vol.12 (8), p.637,IN3-649,IN3

2010

Volltextzugriff (PDF)

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

Journal of translational medicine, 2011-05, Vol.9 (1), p.76-76, Article 76

2011

Volltextzugriff (PDF)

Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis

Cell reports. Medicine, 2021-10, Vol.2 (10), p.100419, Article 100419

2021

Volltextzugriff (PDF)

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Nature (London), 2014-11, Vol.515 (7528), p.568-571

2014

Volltextzugriff (PDF)

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Clinical cancer research, 2018-06, Vol.24 (11), p.2493-2504

2018

Volltextzugriff (PDF)

Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma

Clinical cancer research, 2003-03, Vol.9 (3), p.998-1008

2003

Volltextzugriff (PDF)

T-Cell Responses to HLA-A0201 Immunodominant Peptides Derived from α-Fetoprotein in Patients with Hepatocellular Cancer

Clinical cancer research, 2003-12, Vol.9 (16), p.5902-5908

2003

Volltextzugriff (PDF)

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

Advances in therapy, 2021-07, Vol.38 (7), p.3531-3549

2021

Volltextzugriff (PDF)

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

Journal of translational medicine, 2012-11, Vol.10 (1), p.236-236, Article 236

2012

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(313)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Englisch
(331)
Japanisch
(22)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

BRAF V600E Inhibition in Anaplastic Thyroid Cancer

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial

Do We Need a Different Set of Response Assessment Criteria for Tumor Immunotherapy?

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Pooled Analysis of Individual Patient-Level Data From All Randomized, Double-Blind, Placebo-Controlled Trials of Darbepoetin Alfa in the Treatment of Patients With Chemotherapy-Induced Anemia

Differential Effects of Prostaglandin Derived from ω-6 and ω-3 Polyunsaturated Fatty Acids on COX-2 Expression and IL-6 Secretion

Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

Current Developments in Cancer Vaccines and Cellular Immunotherapy

A careful reassessment of anthracycline use in curable breast cancer

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy

Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade

Pharmacodynamic Characterization of the Efficacy Signals Due to Selective BRAF Inhibition with PLX4032 in Malignant Melanoma

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations

Multiplexed imaging reveals an IFN-γ-driven inflammatory state in nivolumab-associated gastritis

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma

T-Cell Responses to HLA-A0201 Immunodominant Peptides Derived from α-Fetoprotein in Patients with Hepatocellular Cancer

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

Suchergebnisse filtern